BRIEF: De­ci­phera bags a $52M round to back its can­cer drug pipeline work

Waltham, MA-based De­ci­phera Ther­a­peu­tics has been care­ful­ly track­ing the ear­ly-stage progress it’s been mak­ing with its lead drug, a pan-KIT and PDGFR in­hibitor dubbed DCC …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.